• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Associated Factors of Cholelithiasis among Younger Children with Sickle Cell Disease at the National Reference Center for Sickle Cell Disease in Brazzaville, Congo.刚果布拉柴维尔镰状细胞病国家参考中心镰状细胞病患儿胆石症的相关因素
Anemia. 2023 Sep 27;2023:8887981. doi: 10.1155/2023/8887981. eCollection 2023.
2
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.镰状细胞病的管理:专家小组成员 2014 年循证报告的总结。
JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.
3
Pregnancy Outcomes among Patients with Sickle Cell Disease in Brazzaville.布拉柴维尔镰状细胞病患者的妊娠结局
Anemia. 2020 Sep 15;2020:1989134. doi: 10.1155/2020/1989134. eCollection 2020.
4
[Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)].[在布拉柴维尔(刚果)接受羟基脲治疗的纯合子镰状细胞病患儿]
Bull Soc Pathol Exot. 2019;112(4):206-212. doi: 10.3166/bspe-2019-0096.
5
Cholelithiasis and its complications in sickle cell disease in a university hospital.某大学医院镰状细胞病中的胆结石及其并发症
Rev Bras Hematol Hemoter. 2017 Jan-Mar;39(1):28-31. doi: 10.1016/j.bjhh.2016.09.009. Epub 2016 Oct 20.
6
[Evaluation of the Follow-Up and State of Adolescents with Sickle-Cell Disease in Brazzaville (Congo)].
Bull Soc Pathol Exot. 2019;112(4):213-219. doi: 10.3166/bspe-2019-0097.
7
Outcomes of Cholelithiasis Among Patients With Sickle Cell Disease: A Tertiary Care Center Experience.镰状细胞病患者胆石症的治疗结果:三级医疗中心的经验
Cureus. 2023 Mar 27;15(3):e36761. doi: 10.7759/cureus.36761. eCollection 2023 Mar.
8
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2020 Jul 2;7(7):CD003149. doi: 10.1002/14651858.CD003149.pub4.
9
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟基脲素)用于镰状细胞病。
Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD002202. doi: 10.1002/14651858.CD002202.pub2.
10
Gallstones in children with sickle cell disease followed up at a Brazilian hematology center.在巴西一家血液学中心接受随访的镰状细胞病患儿的胆结石情况。
Arq Gastroenterol. 2008 Oct-Dec;45(4):313-8. doi: 10.1590/s0004-28032008000400010.

引用本文的文献

1
Cholecystectomy in Children: Indications and Timing.儿童胆囊切除术:适应证与时机
Children (Basel). 2025 Aug 11;12(8):1052. doi: 10.3390/children12081052.

本文引用的文献

1
[Gallstone complications in sickle cell patients].[镰状细胞病患者的胆结石并发症]
Rev Med Interne. 2022 Aug;43(8):479-486. doi: 10.1016/j.revmed.2022.05.006. Epub 2022 Jun 7.
2
Cholelithiasis in children and adolescents with sickle cell disease: Experience in a resource-limited setting.小儿及青少年镰状细胞病患者的胆石症:资源有限环境下的经验。
Ann Afr Med. 2022 Jan-Mar;21(1):58-64. doi: 10.4103/aam.aam_81_20.
3
Neonatal Screening for Sickle Cell Disease in Congo.刚果的镰状细胞病新生儿筛查
Anemia. 2022 Feb 3;2022:9970315. doi: 10.1155/2022/9970315. eCollection 2022.
4
Correlates of gallbladder stones among patients with sickle cell disease: A meta-analysis.镰状细胞病患者胆囊结石的相关因素:一项荟萃分析。
JGH Open. 2021 Aug 7;5(9):997-1003. doi: 10.1002/jgh3.12622. eCollection 2021 Sep.
5
Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.年轻镰状细胞贫血症患者的尿苷二磷酸葡萄糖醛酸基转移酶 1A(UGT1A1)启动子多态性:来自尼日利亚的首个队列研究报告。
BMC Med Genet. 2019 Oct 16;20(1):160. doi: 10.1186/s12881-019-0899-3.
6
Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients.镰状细胞病患儿的肝胆并发症:616例患者病历的回顾性研究
J Clin Med. 2019 Sep 18;8(9):1481. doi: 10.3390/jcm8091481.
7
Cholelithiasis in patients with paediatric sickle cell anaemia in a Saudi hospital.沙特一家医院中患小儿镰状细胞贫血症患者的胆结石情况
J Taibah Univ Med Sci. 2019 Apr 2;14(2):187-192. doi: 10.1016/j.jtumed.2019.02.007. eCollection 2019 Apr.
8
Acute and chronic hepatobiliary manifestations of sickle cell disease: A review.镰状细胞病的急慢性肝胆表现:综述
World J Gastrointest Pathophysiol. 2017 Aug 15;8(3):108-116. doi: 10.4291/wjgp.v8.i3.108.
9
Sickle Cell Disease.镰状细胞病
N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865.
10
Cholelithiasis and its complications in sickle cell disease in a university hospital.某大学医院镰状细胞病中的胆结石及其并发症
Rev Bras Hematol Hemoter. 2017 Jan-Mar;39(1):28-31. doi: 10.1016/j.bjhh.2016.09.009. Epub 2016 Oct 20.

刚果布拉柴维尔镰状细胞病国家参考中心镰状细胞病患儿胆石症的相关因素

Associated Factors of Cholelithiasis among Younger Children with Sickle Cell Disease at the National Reference Center for Sickle Cell Disease in Brazzaville, Congo.

作者信息

Galiba Atipo Tsiba Firmine Olivia, Mikia Clément Pacha, Elira Samba Jennifer Armandine, Nziengui Mboumba Jade Vanessa, Malanda Félix, Mikolele Ahoui Clausina, Elira Dokekias Alexis

机构信息

National Reference Center for Sickle Cell Disease "Antoinette Sassou Nguesso", Brazzaville, Congo.

Marien Ngouabi University, Brazzaville, Congo.

出版信息

Anemia. 2023 Sep 27;2023:8887981. doi: 10.1155/2023/8887981. eCollection 2023.

DOI:10.1155/2023/8887981
PMID:37799288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10550436/
Abstract

INTRODUCTION

Chronic hemolysis predisposes sickle cell patients to the development of gallstones. Their frequency increases with age, but they may appear early in young children. In the absence of management, they expose the patient to complications that can hinder the quality of life and sometimes even death. This survey aimed to identify the associated factors of the occurrence of cholelithiasis.

MATERIALS AND METHODS

It was a case-control study carried out between January 2017 and June 2022 at the National Reference Center for Sickle Cell Disease (SCD) "Antoinette Sassou N'guesso" in Brazzaville. It concerned 37 children with cholelithiasis. Sociodemographic (socioeconomic status and diet) and clinical (body mass index, frequency of vasoocclusive crises and hospitalization for vasoocclusive crises, number of blood transfusion, and chronic complications) as well as hematological examination (type of SCD and blood count in the intercritical period) and hydroxyurea treatment were compared with those of 74 children with no clinical and radiographic signs of cholelithiasis. The chi-squared statistical test and the odds ratio were used for the comparison (  <  0.05).

RESULTS

The average age was 9.70 ± 1.73 years. The 10-12 age group was the most represented (22 cases or 59.45%), followed by 7- to 9-year-olds (12 cases or 32.43%). Three children (8.10%) were 6  years old. The sex ratio was 0.68 1.38. Factors associated with cholelithiasis were low socioeconomic status (83.78% 45.95%; IC 95% 1.46-3.89; ≤ 0.001), a higher number of blood transfusions (5.54 ± 1.22 2.46 ± 1.13; IC 95% 1.55-6.70; ≤ 0.001), and irregular systematic monitoring (5.54 ± 1.22 2.46 ± 1.13; IC 95% 1.55-6.70; ≤ 0.001).

CONCLUSION

A national strategy to facilitate access to care for patients living with sickle cell disease is imperative. Moreover, emphasis should be placed on the prevention and early management of acute complications of SCD.

摘要

引言

慢性溶血使镰状细胞病患者易患胆结石。胆结石的发病率随年龄增长而增加,但也可能在幼儿期就出现。若不加以治疗,会使患者面临可能影响生活质量甚至危及生命的并发症。本调查旨在确定胆结石发生的相关因素。

材料与方法

这是一项病例对照研究,于2017年1月至2022年6月在布拉柴维尔的国家镰状细胞病参考中心“安托瓦内特·萨苏·恩古索”进行。研究对象为37例胆结石患儿。将其社会人口学特征(社会经济状况和饮食)、临床特征(体重指数、血管闭塞性危机发作频率及因血管闭塞性危机住院情况、输血次数、慢性并发症)、血液学检查结果(镰状细胞病类型及病情缓解期血常规)以及羟基脲治疗情况与74例无胆结石临床及影像学征象的患儿进行比较。采用卡方统计检验和比值比进行比较(P<0.05)。

结果

平均年龄为9.70±1.73岁。10至12岁年龄组占比最高(22例,占59.45%),其次是7至9岁年龄组(12例,占32.43%)。3名患儿(8.10%)为6岁。男女比例为0.68比1.38。与胆结石相关的因素包括社会经济地位低(83.78%比45.95%;95%置信区间1.46 - 3.89;P≤0.001)、输血次数较多(5.54±1.22比2.46±1.13;95%置信区间1.55 - 6.70;P≤0.001)以及缺乏定期系统监测(5.54±1.22比2.46±1.13;95%置信区间1.55 - 6.70;P≤0.001)。

结论

必须制定一项国家战略,以方便镰状细胞病患者获得医疗服务。此外,应重视镰状细胞病急性并发症的预防和早期治疗。